Research ArticleClinical Studies

First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery

AKIRA INOUE, HIROFUMI OTA, YUSUKE MATSUURA, KOJI MUNAKATA, MASATAKA FUJIWARA, KOSUKE NISHIHARA, RYUTARO WADA, RYOHEI WADA, YU TAKEDA, SAKAE MAEDA and KOU TAKACHI
Anticancer Research February 2026, 46 (2) 975-985; DOI: https://doi.org/10.21873/anticanres.18003

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
First-line FOLFOXIRI-based Chemotherapy for Unresectable Metastatic Colorectal Cancer: Real-world Outcomes, Safety, and Conversion Surgery
AKIRA INOUE, HIROFUMI OTA, YUSUKE MATSUURA, KOJI MUNAKATA, MASATAKA FUJIWARA, KOSUKE NISHIHARA, RYUTARO WADA, RYOHEI WADA, YU TAKEDA, SAKAE MAEDA, KOU TAKACHI
Anticancer Research Feb 2026, 46 (2) 975-985; DOI: 10.21873/anticanres.18003
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords